Supplementary Tables 9-17 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes

Read full text Summarise with VIRAT
Authors: Benedetta Conte, Fara Brasó‐Maristany, Tomás Pascual, Cristina Hernándo, Silvia Vázquez, Salvador Blanch, Mafalda Oliveira, Juan Antonio Virizuela, Montse Muñoz, Elia Seguí, Adela Rodriguez-Hernandez, Maria Jesus Vidal
+14 more Patricia Galván, Oleguer Castillo, Paula Blasco, Manuel Alva, Núria Chic, Esther Sanfeliu, Sara Cano-Crespo, Fernando Salvador, Guillermo Javierre Villacampa, Lorea Villanueva, Juan Manuel Ferrero-Cafiero, Ana P. Vivancos, Aleix Prat, Eva Ciruelos
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tables S9-S17 showing mutivariate and bivariate analysis for ORR, CBR, PFS and OS

Fields of Study & Subjects

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies Cancer Immunotherapy and Biomarkers

Publication details

Publication date
1 April 2026
Language
EN